Justin R Bingaman1, Swetha J Sundar2, Jason K Hsieh2, Elaine Lu1, Lara Jehi3, Elaine Wyllie3, Ajay Gupta3, Richard Prayson4, William E Bingaman5. 1. Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. 2. Department of Neurological Surgery, Cleveland Clinic, Cleveland, Ohio, USA. 3. The Charles Shor Center for Epilepsy, Cleveland Clinic, Cleveland, Ohio, USA. 4. Department of Neuropathology, Cleveland Clinic, Cleveland, Ohio, USA. 5. Department of Neurological Surgery, Cleveland Clinic, Cleveland, Ohio, USA; The Charles Shor Center for Epilepsy, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: bingamb@ccf.org.
Abstract
OBJECTIVE: The objectives of this study were to determine the relationship between the severity of pathology and seizure outcomes in patients who underwent hemispherectomy for Rasmussen encephalitis (RE) and to investigate which clinical factors correlated with severity of pathology. METHODS: In this retrospective cohort study, we collected and reviewed pathology and clinical variables. We ascertained seizure outcomes using Engel's classification, and Pardo stages were used to grade pathology. RESULTS: We included 29 unique patients who underwent 34 hemispherectomy procedures for analysis. There was no statistically significant correlation between Pardo stage and seizure outcome (P = 1). Increasing duration of epilepsy (β = 0.011, P = 0.02) and duration of hemiparesis (β = 0.024, P = 0.01) were significantly associated with a more severe Pardo stage. In contrast, the presence of epilepsia partialis continua had a negative relationship with Pardo stage (β = -0.49, P = 0.04). Twenty-six (89.75%) patients were Engel class I at the last follow-up, including all 5 patients who underwent redo hemispherectomy in our cohort. CONCLUSIONS: Consistent with the progressive nature of RE, more severe pathology was associated with a longer duration of epilepsy and longer duration of hemiparesis, while the presence of epilepsia partialis continua was associated with less severe pathology. Results from this series suggest the degree of cortical involvement with RE as assessed on surgical histopathology does not correlate with seizure outcome after hemispherectomy, which appears to be more dependent on surgical technique/complete disconnection.
OBJECTIVE: The objectives of this study were to determine the relationship between the severity of pathology and seizure outcomes in patients who underwent hemispherectomy for Rasmussen encephalitis (RE) and to investigate which clinical factors correlated with severity of pathology. METHODS: In this retrospective cohort study, we collected and reviewed pathology and clinical variables. We ascertained seizure outcomes using Engel's classification, and Pardo stages were used to grade pathology. RESULTS: We included 29 unique patients who underwent 34 hemispherectomy procedures for analysis. There was no statistically significant correlation between Pardo stage and seizure outcome (P = 1). Increasing duration of epilepsy (β = 0.011, P = 0.02) and duration of hemiparesis (β = 0.024, P = 0.01) were significantly associated with a more severe Pardo stage. In contrast, the presence of epilepsia partialis continua had a negative relationship with Pardo stage (β = -0.49, P = 0.04). Twenty-six (89.75%) patients were Engel class I at the last follow-up, including all 5 patients who underwent redo hemispherectomy in our cohort. CONCLUSIONS: Consistent with the progressive nature of RE, more severe pathology was associated with a longer duration of epilepsy and longer duration of hemiparesis, while the presence of epilepsia partialis continua was associated with less severe pathology. Results from this series suggest the degree of cortical involvement with RE as assessed on surgical histopathology does not correlate with seizure outcome after hemispherectomy, which appears to be more dependent on surgical technique/complete disconnection.
Authors: Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross Journal: Lancet Neurol Date: 2014-02 Impact factor: 44.182
Authors: Tiziana Granata; Sara Matricardi; Francesca Ragona; Elena Freri; Marina Casazza; Flavio Villani; Francesco Deleo; Giovanni Tringali; Giuseppe Gobbi; Laura Tassi; Giorgio Lo Russo; Carlo Efisio Marras; Nicola Specchio; Federico Vigevano; Lucia Fusco Journal: Epilepsy Res Date: 2014-04-08 Impact factor: 3.045
Authors: William B Harris; H Westley Phillips; Jia Shu Chen; Alexander G Weil; George M Ibrahim; Aria Fallah Journal: J Neurosurg Pediatr Date: 2019-12-06 Impact factor: 2.375
Authors: C G Bien; T Granata; C Antozzi; J H Cross; O Dulac; M Kurthen; H Lassmann; R Mantegazza; J-G Villemure; R Spreafico; C E Elger Journal: Brain Date: 2005-02-02 Impact factor: 13.501
Authors: Anna L R Pinto; Subash Lohani; Ann M R Bergin; Blaise F D Bourgeois; Peter M Black; Sanjay P Prabhu; Joseph R Madsen; Masanori Takeoka; Annapurna Poduri Journal: Pediatr Neurol Date: 2014-05-22 Impact factor: 3.372